Pfizer Stops Sutent Trial Early; Drug Shows Definite BenefitCNNMoney.comPfizer Inc. (PFE) said Thursday that it has stopped a Phase 3 trial of its drug Sutent early after the drug showed "significant benefit" in patients with advanced pancreatic islet cell tumors.Pfizer halts trial for cancer drug after seeing benefit MarketWatchPfizer ends Sutent trial early on positive data BusinessWeekReuters - TheStreet.com - RTT News - MSN Moneyall 31 news articles